News

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

The NIH awarded more than $8.3 million to study 1,000 pregnant individuals with heart conditions in an effort to combat maternal mortality and morbidity.

The four-year observational study will research U.S. pregnant people with cardiovascular disease to better understand and combat maternal mortality and morbidity.

Jennifer Sonsiadek, Nurse Manager of Saint Luke’s Clinical Forensic Program, talks to KCTV about how Saint Luke’s has been leading the way and innovating clinical forensic care provided in Kansas City and the nation for 50 years.

The care a person receives immediately following abuse or assault has a significant effect on their physical, emotional, and psychological well-being.

Dr. Rebecca Lobell shares what causes infertility and when a person should talk to their doctor about issues conceiving.

KCTV talked to Dr. Rebecca Lobell about infertility and the steps a woman can take when she is trying to conceive.

Saint Luke’s has been delivering babies for 135 years. To honor this anniversary, we are taking a look back at Kansas City through the decades.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

Over the years, they have done everything together: graduated high school, tied the knot, bought their first home, and raised a family. For all they have shared, they never dreamed of sharing a cancer diagnosis.